The Trump administration’s most recent effort to use the immediate COVID-19 evidence, touted through a senior official as a “turning point” in preventing the spread of coronavirus in nursing homes, faces obstacles that may limit its use.
The federal government is distributing point-of-service antigenic testing, which is less expensive and faster than lab tests, to 14,000 retirement homes to develop a citizen and personnel screening regime. The initial distribution targets retirement homes in hot spots and those with at least 3 coVID-19 instances, senior Trump administration officials said in July, hailing it as a tool that can simply be asymptomatic carriers that can still infect others.
But there’s a catch: two brands that got approval from the Food and Drug Administration and whose tools are delivered, Becton, Dickinson and Co., known as BD and Quidel, say their antigen tests are aimed at patients with symptoms. wondering the price of tests for general detection purposes. The Centers for Disease Control and Prevention estimates that 40% of inflamed people can be asymptomatic.
“It’s vital to use a diagnosis of the way it was designed,” said Elizabeth Talbot, an assistant epidemiologist for the state of New Hampshire. “We just don’t know what [the tests] will look like in asymptomatic people.”
Perhaps the ultimate visual example of the challenge occurred in Ohio this month, when Gov. Mike DeWine had no symptoms and tested positive for COVID-19 with the Quidel antigenic test. Within hours, the Republican governor’s diagnosis was reversed after undergoing a PCR test.
“People shouldn’t walk away from my delight that the tests are reliable or don’t work,” DeWine said on CNN after his false positive diagnosis. “Antigen tests are pretty recent,” he said. “We’re going to be very careful in the way we use it.”
Subscribe to the khN weekly weekly newsletter.
The biggest challenge is false negative results, which show that a user is not inflamed when inflamed. The negative rate of fake comedian e-books (how often a check incorrectly indicates that a user is not inflamed) is approximately 15%; Quidel is 3%.
Quidel and BD say their controls are intended to be used in others within the first five days of the onset of symptoms. A BD spokesperson said its control should not be used in asymptomatic people. Quidel, through a spokesperson, referred to FDA guidelines, which allow asymptomatic control in certain scenarios.
“For regime monitoring, it’s a wonderful tool and those are our most productive teams we have,” said Admiral Brett Giroir, undersecretary of health at the Department of Health and Human Services, in a July call with nursing officials, founded on a recording received through KHN. Seema Verma, the administrator of the Federal Centers for Medicare and Medicaid Services, called the effort a “turning point” in the fight against the virus.
A month after the initial announcement, Trump’s management invoked the Defense Production Act to delay their contracts with the two front-line corporations and speed up shipments. BD will send approximately 11,000 devices and 3.75 million tests to nursing homes; Quidel and HHS refused to answer questions about their volume.
As states and the federal government take steps to make COVID screening mandatory in nursing homes, where patients are highly vulnerable to infections and serious complications, several industry officials said they hoped to use the tests on asymptomatic people. But many states restrict the use of antigen tests or still require lab tests due to accuracy issues.
If a user with a negative result is going to use a more accurate PCRArray by default, “we’ve just added time and costs,” Talbot said. “It’s a problem.”
Officials said the announcement of antigen verification surprised them, underlining the administration’s chaotic verification strategy. Regardless of the federal effort, 10 states have combined through the Rockefeller Foundation to download five million checks from any of the corporations in hopes of reducing the spread of the virus this fall.
Once the retirement homes have earned a first batch of tests (each establishment receives between 150 and 900), they buy long-term supplies. Medicare will cover the prices of diagnostic tests, but not the costs of tracking the regime.
“I just have a lot of skepticism,” said Brendan Williams, president of the New Hampshire Health Care Association, which represents retirement homes and service apartments in the state. “Basically, you do terrible tests for retirement homes and make them pay for them. I see it as a victory, I see it as a risk.
Public fitness experts are increasingly told that common immediate testing is the most productive tool to prevent the virus, killing more than 174,000 Americans and tens of thousands in nursing than relying on more accurate lab tests that have been plagued by fitness problems. delays and scarcity. In a phone call this month with the industry, Verma estimated that some of the country’s nursing homes have experienced cases.
“I don’t see any streets where it probably doesn’t help prevent transmission chains, and I don’t see any other options on the table for us,” said Dr. Michael Mina, assistant professor of epidemiology at Harvard T.H. Chan School of Public Health and a supporter of immediate testing. “That’s what we want to do now.”
“It’s certainly better for other people in our buildings,” said Jason Belden, director of emergency preparedness and physical services at the California Health Facilities Association.
In theory, antigenic testing can have a dual purpose: to diagnose a suspicious user of infection or to examine an organization of others to identify others with health problems more quickly. Quidel and BD tests, according to FDA approvals, would possibly be used in certain asymptomatic people, adding those suspected to have COVID-19 after exposure to an inflamed user. Companies would want increased FDA approval for asymptomatic, whether they are suspected of being sick or not, as directed by the agency.
The CDC cautioned that antigen testing can be useful in high-risk environments if performed repeatedly. It stated that there was limited knowledge to consult its use in the detection of asymptomatic people.
However, HHS recommends universal detection of citizens of nursing homes at least once and normal detection of staff, regardless of symptoms, said company spokeswoman Mia Heck, and mentioned the fact that COVID-19 viral occurs among patients with and without symptoms. “Only one check is allowed in the U.S. For asymptomatic people,” he said, referring to a LabCorp PCR check, “but the vast majority of verifications are done on asymptomatic people.”
“If the global were ideal, we would say, “Oh, we need the maximum precise verification.” But the maximum accurate verification is needed to get the results,” said Peter Van Runkle, executive director of the Ohio Health Association, which represents the state’s retirement homes.
All selected nursing homes will get checks until the end of September, according to federal officials, who recently announced that services in states with a positivity rate of at least 5% should check staff weekly.
“I don’t see this as a federal strategy, but rather as an interim approach to providing some relief to nursing homes,” said Katie Smith Sloan, president of LeadingAge, which represents nonprofit nursing homes. “It’s tragic that we’re where we are now.”
With $71 million in federal investment for Quidel and $24.3 million for comics, Quidel plans to produce 1.8 million tests according to the week through September; BD will produce volumes until October.
“The scenario is too pressing to wait a few months for us to put knots and lipstick in the program. So we’re going to build this plane a little while we blow it up,” Giroir told the retirement homes in July. “Just paint with us. We have to give you what you need. And then, in September, October, you can get what you need.”
States are taking other approaches to implementing antigenic testing in nursing homes; in at least seven, including California, Illinois and Maryland, officials say PCR tests deserve to be used to verify the effects or evaluate patients without symptoms. In Massachusetts, nursing homes will need to use PCR tests to meet tracking requirements.
In Maryland, “our purpose is to help staff as temporarily as possible, especially asymptomatic people,” said Dennis Schrader, chief operating officer of the Department of Health.
Maryland nursing homes can use antigenic testing for weekly staff testing if there is no outbreak. But if at least one user tests positive for coronavirus, all staff and citizens will undergo PCR testing.
Share this story:
The Trump administration’s most recent effort to use the immediate COVID-19 evidence, touted through a senior official as a “turning point” in preventing the spread of coronavirus in nursing homes, faces obstacles that may limit its use.
The federal government is distributing point-of-service antigenic testing, which is less expensive and faster than lab tests, to 14,000 retirement homes to develop a citizen and personnel screening regime. The initial distribution targets retirement homes in hot spots and those with at least 3 coVID-19 instances, senior Trump administration officials said in July, hailing it as a tool that can simply be asymptomatic carriers that can still infect others.
But there’s a catch: two brands that got approval from the Food and Drug Administration and whose tools are being delivered, Becton, Dickinson and Co., known as BD and Quidel, say their antigen tests are aimed at patients with symptoms. wondering the price of tests for general detection purposes. The Centers for Disease Control and Prevention estimates that 40% of inflamed people can be asymptomatic.
“It’s vital to use a diagnosis of the way it was designed,” said Elizabeth Talbot, an assistant epidemiologist for the state of New Hampshire. “We just don’t know what [the tests] will look like in asymptomatic people.”
Perhaps the ultimate visual example of the challenge occurred in Ohio this month, when Gov. Mike DeWine had no symptoms and tested positive for COVID-19 with the Quidel antigenic test. Within hours, the Republican governor’s diagnosis was reversed after undergoing a PCR test.
“People shouldn’t walk away from my delight that the tests are reliable or don’t work,” DeWine said on CNN after his false positive diagnosis. “Antigen tests are pretty recent,” he said. “We’re going to be very careful in the way we use it.”
The Trump administration’s most recent effort to use the immediate COVID-19 evidence, touted through a senior official as a “turning point” in preventing the spread of coronavirus in nursing homes, faces obstacles that may limit its use.
The federal government is distributing point-of-service antigen tests, which are less expensive and faster than lab tests, to 14,000 retirement homes to develop a citizen and personnel screening regime. The initial distribution targets retirement homes in hot spots and those with at least 3 coVID-19 instances, senior Trump administration officials said in July, hailing it as a tool that can simply be asymptomatic carriers that can still infect others.
But there’s a catch: two brands that got approval from the Food and Drug Administration and whose tools are delivered, Becton, Dickinson and Co., known as BD and Quidel, say their antigen tests are aimed at patients with symptoms. wondering the price of tests for general detection purposes. The Centers for Disease Control and Prevention estimates that 40% of inflamed people can be asymptomatic.
“It’s vital to use a diagnosis of the way it was designed,” said Elizabeth Talbot, an assistant epidemiologist for the state of New Hampshire. “We just don’t know what [the tests] will look like in asymptomatic people.”
Perhaps the ultimate visual example of the challenge occurred in Ohio this month, when Gov. Mike DeWine had no symptoms and tested positive for COVID-19 with the Quidel antigenic test. Within hours, the Republican governor’s diagnosis was reversed after undergoing a PCR test.
“People shouldn’t walk away from my delight that the tests are reliable or don’t work,” DeWine said on CNN after his false positive diagnosis. “Antigen tests are pretty recent,” he said. “We’re going to be very careful in the way we use it.”
The biggest challenge is false negative results, which show that a user is not inflamed when inflamed. The negative rate of fake comedian e-books (how often a check incorrectly indicates that a user is not inflamed) is about 15%; Quidel is 3%.
Quidel and BD say their controls are intended to be used in others within the first five days of the onset of symptoms. A BD spokesperson said its control should not be used in asymptomatic people. Quidel, through a spokesperson, referred to FDA guidelines, which allow asymptomatic control in certain scenarios.
“For regime monitoring, it’s a wonderful tool and it’s our most productive tool,” Said Admiral Brett Giroir, undersecretary of fitness at the Department of Health and Human Services, on a July call with nursing officials, according to a recording received. via KHN. Seema Verma, the administrator of the Federal Centers for Medicare and Medicaid Services, called the effort a “turning point” in the fight against the virus.
A month after the initial announcement, Trump’s management invoked the Defense Production Act to delay their contracts with the two front-line corporations and speed up shipments. BD will send approximately 11,000 devices and 3.75 million tests to nursing homes; Quidel and HHS refused to answer questions about their volume.
As states and the federal government take steps to make COVID screening mandatory in nursing homes, where patients are highly vulnerable to infections and serious complications, several industry officials have said they expect to use tests on asymptomatic people. But many states restrict the use of antigen tests or still require lab tests due to accuracy issues.
If a user with a negative result is going to use a more accurate PCRArray by default, “we’ve just added time and costs,” Talbot said. “It’s a problem.”
Officials said the announcement of antigen verification surprised them, underlining the administration’s chaotic verification strategy. Regardless of the federal effort, 10 states have combined through the Rockefeller Foundation to download five million checks from any of the corporations in hopes of reducing the spread of the virus this fall.
Once nursing homes have earned a first batch of tests (each facility receives between 150 and 900), they buy long-term supplies. Medicare will cover the prices of diagnostic tests, but not the costs of tracking the regime.
“I just have a lot of skepticism,” said Brendan Williams, president of the New Hampshire Health Care Association, which represents the state’s retirement homes and service residences. “Basically, you do terrible tests for retirement homes and make them pay for them. I see it as a victory, I see it as a risk.
Public fitness experts are increasingly told that common immediate testing is the most productive tool to prevent the virus, killing more than 174,000 Americans, adding up tens of thousands in nursing, than relying on more accurate lab tests that have been plagued by delays and scarcity. In a phone call this month with the industry, Verma estimated that some of the country’s nursing homes have experienced cases.
“I don’t see any streets where it probably doesn’t help prevent transmission chains, and I don’t see any other options on the table for us,” said Dr. Michael Mina, assistant professor of epidemiology at Harvard T.H. Chan School of Public Health and a supporter of immediate testing. “That’s what we want to do now.”
“It’s certainly better for other people in our buildings,” said Jason Belden, director of emergency preparedness and physical services at the California Health Facilities Association.
In theory, antigenic testing can have a dual purpose: to diagnose a suspicious user of infection or to examine an organization of others to identify others with health problems more quickly. Quidel and BD tests, according to FDA approvals, would possibly be used in certain asymptomatic people, adding those suspected to have COVID-19 after exposure to an inflamed user. Companies would want increased FDA approval for asymptomatic, whether they are suspected of being sick or not, as directed by the agency.
The CDC cautioned that antigen testing can be useful in high-risk environments if performed repeatedly. It stated that there was limited knowledge to consult its use in the detection of asymptomatic people.
However, HHS recommends universal detection of citizens of nursing homes at least once and normal detection of staff, regardless of symptoms, said company spokeswoman Mia Heck, and mentioned the fact that COVID-19 viral occurs among patients with and without symptoms. “Only one check is allowed in the U.S. For asymptomatic people,” he said, referring to a LabCorp PCR check, “but the vast majority of verifications are done on asymptomatic people.”
“If the global were ideal, we would say, “Oh, we need the maximum precise verification.” But maximum accurate verification is needed to get the results,” said Peter Van Runkle, executive director of the Ohio Health Care Association, which represents the state’s retirement homes.
All selected nursing homes will get checks until the end of September, according to federal officials, who recently announced that services in states with a positivity rate of at least 5% should check staff weekly.
“I don’t see this as a federal strategy, but rather as an interim approach to providing some relief to nursing homes,” said Katie Smith Sloan, president of LeadingAge, which represents nonprofit nursing homes. “It’s tragic that we’re where we are now.”
With $71 million in federal investment for Quidel and $24.3 million for comics, Quidel plans to produce 1.8 million tests according to the week through September; BD will produce volumes until October.
“The scenario is too pressing to wait a few months for us to put knots and lipstick in the program. So we’re going to build this plane a little while we blow it up,” Giroir told the retirement homes in July. “Just paint with us. We have to give you what you need. And then, in September, October, you can get what you need.”
States are taking other approaches to implementing antigenic testing in nursing homes; in at least seven countries, including California, Illinois and Maryland, officials say PCR testing is still used to verify the effects or evaluate patients without symptoms. In Massachusetts, nursing homes will need to use PCR tests to meet tracking requirements.
In Maryland, “our purpose is to help staff as temporarily as possible, especially asymptomatic people,” said Dennis Schrader, chief operating officer of the Department of Health.
Maryland nursing homes can use antigenic testing for weekly staff testing if there is no outbreak. But if at least one user tests positive for coronavirus, all staff and citizens will undergo PCR testing.
The biggest challenge is false negative results, which show that a user is not inflamed when inflamed. The negative rate of fake comedian e-books (how often a check incorrectly indicates that a user is not inflamed) is approximately 15%; Quidel is 3%.
Quidel and BD say their controls are intended to be used in others within the first five days of the onset of symptoms. A BD spokesperson said its control should not be used in asymptomatic people. Quidel, through a spokesperson, referred to FDA guidelines, which allow asymptomatic control in certain scenarios.
“For regime monitoring, it’s a wonderful tool and those are our most productive teams we have,” said Admiral Brett Giroir, undersecretary of health at the Department of Health and Human Services, in a July call with nursing officials, founded on a recording received through KHN. Seema Verma, the administrator of the Federal Centers for Medicare and Medicaid Services, called the effort a “turning point” in the fight against the virus.
A month after the initial announcement, Trump’s management invoked the Defense Production Act to delay their contracts with the two front-line corporations and speed up shipments. BD will send approximately 11,000 devices and 3.75 million tests to nursing homes; Quidel and HHS refused to answer questions about their volume.
As states and the federal government take steps to make COVID screening mandatory in nursing homes, where patients are highly vulnerable to infections and serious complications, several industry officials have said they expect to use tests on asymptomatic people. But many states restrict the use of antigen tests or still require lab tests due to accuracy issues.
If a user with a negative result is going to use a more accurate PCRArray by default, “we just added time and costs,” Talbot said. “It’s a problem.”
Officials said the announcement of antigen verification surprised them, underlining the administration’s chaotic verification strategy. Regardless of the federal effort, 10 states have combined through the Rockefeller Foundation to download five million checks from any of the corporations in hopes of reducing the spread of the virus this fall.
Once nursing homes have earned a first batch of tests (each facility receives between 150 and 900), they buy long-term supplies. Medicare will cover the prices of diagnostic tests, but not the costs of tracking the regime.
“I just have a lot of skepticism,” said Brendan Williams, president of the New Hampshire Health Care Association, which represents retirement homes and service apartments in the state. “Basically, you do terrible tests for retirement homes and make them pay for them. I see it as a victory, I see it as a risk.
Public fitness experts are increasingly told that common immediate testing is the most productive tool to prevent the virus, killing more than 174,000 Americans, adding up tens of thousands in nursing, than relying on more accurate lab tests that have been plagued by delays and scarcity. In a phone call this month with the industry, Verma estimated that some of the country’s nursing homes have experienced cases.
“I don’t see any streets where it probably doesn’t help prevent transmission chains, and I don’t see any other options on the table for us,” said Dr. Michael Mina, assistant professor of epidemiology at Harvard T.H. Chan School of Public Health and a supporter of immediate testing. “That’s what we want to do now.”
“It’s certainly better for other people in our buildings,” said Jason Belden, director of emergency preparedness and physical services at the California Health Facilities Association.
In theory, antigenic testing can have a dual purpose: to diagnose a suspicious user of infection or to examine an organization of others to identify others with health problems more quickly. Quidel and BD tests, according to FDA approvals, would possibly be used in certain asymptomatic people, adding those suspected to have COVID-19 after exposure to an inflamed user. Companies would want increased FDA approval for asymptomatic, whether they are suspected of being sick or not, as directed by the agency.
The CDC cautioned that antigen testing can be useful in high-risk environments if performed repeatedly. It stated that there was limited knowledge to consult its use in the detection of asymptomatic people.
However, HHS recommends universal detection of citizens of nursing homes at least once and normal detection of staff, regardless of symptoms, said company spokeswoman Mia Heck, and mentioned the fact that COVID-19 viral occurs among patients with and without symptoms. “Only one check is allowed in the U.S. For asymptomatic people,” he said, referring to a LabCorp PCR check, “but the vast majority of verifications are done on asymptomatic people.”
“If the global were ideal, we would say, “Oh, we need the maximum precise verification.” But the maximum accurate verification is needed to get the results,” said Peter Van Runkle, executive director of the Ohio Health Association, which represents the state’s retirement homes.
All selected nursing homes will get checks until the end of September, according to federal officials, who recently announced that services in states with a positivity rate of at least 5% should check staff weekly.
“I don’t see this as a federal strategy, but rather as an interim approach to providing some relief to nursing homes,” said Katie Smith Sloan, president of LeadingAge, which represents nonprofit nursing homes. “It’s tragic that we’re where we are now.”
With $71 million in federal investment for Quidel and $24.3 million for comics, Quidel plans to produce 1.8 million tests according to the week through September; BD will produce volumes until October.
“The scenario is too pressing to wait a few months for us to put knots and lipstick in the program. So we’re going to build this plane a little while we blow it up,” Giroir told the retirement homes in July. “Just paint with us. We have to give you what you need. And then, in September, October, you can get what you need.”
States are taking other approaches to implementing antigenic testing in nursing homes; in at least seven, including California, Illinois and Maryland, officials say PCR tests deserve to be used to verify the effects or evaluate patients without symptoms. In Massachusetts, nursing homes will need to use PCR tests to meet tracking requirements.
In Maryland, “our purpose is to help staff as temporarily as possible, especially asymptomatic people,” said Dennis Schrader, the department’s leading chief operating officer of the Department of Health.
Maryland nursing homes can use antigenic testing for weekly staff testing if there is no outbreak. But if at least one user tests positive for coronavirus, all staff and citizens will undergo PCR testing.
We inspire organizations to republish our content free of charge. Here’s what we asked:
You must credit us as the original publisher, with a link to our site khn.org. If possible, come with the original(s) and Kaiser Health News at the signature. Please keep the links in the story.
It is vital to note that everything in khn.org cannot be republished. If a story is classified as “All Rights Reserved”, we cannot grant permission to republish that item.
Do you have any questions? Let us know [email protected]
Thank you for your interest in supporting Kaiser Health News (KHN), the country’s premier nonprofit fitness and fitness policy writing room. We distribute our journalism without fees and advertising through media partners of all sizes and in small, giant communities. We appreciate all the participation bureaucracy of our readers and listeners, and we appreciate your support.
KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can KHN by making a contribution to KFF, a nonprofit that is not related to Kaiser Permanente.
Click the button below the KFF donation page that will provide more information and FAQs. Thank you!